You have 9 free searches left this month | to do more

ruxolitinib

Ruxolitinib is a drug used to treat Myelofibrosis, Primary Myelofibrosis, Polycythemia Vera, and other conditions. Ruxolitinib is being actively studied in 86 studies and prior, has been studied in 50.

Top SponsorsTop SitesTop Investigators
Incyte CorporationNovartis Investigative SiteGabriela Hobbs
Novartis PharmaceuticalsCleveland ClinicIvan S Moiseev
M.D. Anderson Cancer CenterMassachusetts General HospitalJohn Mascarenhas
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • T Cell Leukemia, Adult
  • +2 more
  • Ruxolitinib
  • ruxolitinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-01-11
Jan 11, 2022
U
Withdrawn
  • COVID-19
  • Ruxolitinib
  • (no location specified)
2021-03-03
Mar 3, 2021
A
Active, not recruiting
  • Necrobiosis Lipoidica
  • Ruxolitinib
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
2021-12-27
Dec 27, 2021
W
Terminated
  • Myelofibroses
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-12-16
Dec 16, 2021
B
Not yet recruiting
  • Macrophage Activation Syndrome
  • (no location specified)
2021-11-29
Nov 29, 2021
I
No longer available
  • COVID-19
  • Ruxolitinib
  • (no location specified)
2021-12-01
Dec 1, 2021
U
Not yet recruiting
  • Discoid Lupus Erythematosus
  • Ruxolitinib
  • Rochester, New York
    UR Medicine Dermatology College Town
2021-12-08
Dec 8, 2021
M
Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Steroid Refractory Graft Versus Host Disease
  • Cellular Therapy
  • Ruxolitinib
  • Houston, Texas
    M D Anderson Cancer Center
2021-12-29
Dec 29, 2021
N
Recruiting
  • Colorectal Cancer
  • Pancreatic Adenocarcinoma
  • Singapore, Singapore
    National Cancer Centre
2021-05-24
May 24, 2021
C
Recruiting
  • Glioma
  • Glioblastoma
  • ruxolitinib
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
2021-06-01
Jun 1, 2021
U
Completed
  • Hemophagocytic Syndrome (HPS)
  • Ruxolitinib
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
2021-01-04
Jan 4, 2021
C
Recruiting
  • Hematopoietic Stem Cell Transplant (HSCT)
  • Bronchiolitis Obliterans (BO)
  • Ruxolitinib
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
2021-11-17
Nov 17, 2021
C
Recruiting
  • Acute-graft-versus-host Disease
  • Chronic Graft-versus-host-disease
  • Ruxolitinib
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
2021-11-03
Nov 3, 2021
D
Completed
  • Recurrent Breast Cancer
  • Metastatic Breast Cancer
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-03-26
Mar 26, 2021
M
Recruiting
  • Other Cancer
  • ruxolitinib
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-09-30
Sep 30, 2021
U
Terminated
  • COVID-19
  • Pneumonia
  • Ruxolitinib
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-08-13
Aug 13, 2021
W
Recruiting
  • Myelofibrosis
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-05-05
May 5, 2021
N
No longer available
  • Severe/Very Severe COVID-19 Illness
  • Ruxolitinib
  • (no location specified)
2021-01-22
Jan 22, 2021
U
Completed
  • Hodgkin's Lymphoma
  • Lymphoma, Non-Hodgkin
  • Ann Arbor, Michigan
    University of Michgan Comprehensive Cancer Center
2021-12-03
Dec 3, 2021
U
Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Ruxolitinib
  • Tucson, Arizona
  • +1 more
2021-08-04
Aug 4, 2021
M
Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Ruxolitinib
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-07-23
Jul 23, 2021
T
Recruiting
  • Safety and Efficacy
  • Ruxolitinib
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
2021-08-23
Aug 23, 2021
M
Completed
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Untreated Chronic Lymphocytic Leukemia
  • Ruxolitinib
  • Ruxolitinib Phosphate
  • Houston, Texas
    M D Anderson Cancer Center
2021-03-23
Mar 23, 2021
U
Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Ruxolitinib
  • +12 more
  • Chicago, Illinois
    University of Chicago Medical Center
2021-09-14
Sep 14, 2021
V
Recruiting
  • Hodgkin Lymphoma
  • Chicago, Illinois
  • +3 more
2021-08-17
Aug 17, 2021